NARA
PanGenomic Health Inc
Access
ISIN
CA69842E2050
Bid
3.50
Mid
4.00
Ask
4.50
Key Information
- Price Change
- 0.00%
- Year High
- 4.50
- Year Low
- 4.00
- Market Cap
- £3.97M
- Par
- 0.00
- Bid
- 3.50
- Mid Price
- 4.00
- Ask
- 4.50
- Instrument Type
- Ordinary Shares
- MIFID Status
- MTF
- Tradable Securities
- 99.13M
- Sector
- Healthcare
Prices in GBX except for Market Cap in GBP
About PanGenomic Health Inc
The Company is a precision health company that has developed a self-care digital platform to deliver personalised, evidence-based information about natural treatments to support mental health. The Company has three platforms: Nara App - a mental health mobile app which provides consumers with a knowledge base tailored to an individual's unique user profile, developed by tracking a user's treatment regimen and their specific genomic, proteomics and microbiomic data. indleap.com - and app and telehealth platform for holistirc mental wellness which grants users access to great audio content and blogs, a mental health tracker, and access to professional services for mental well-being. The Company's digital therapeutics clinic platform, the PlantGx Platform, provides health practitioners with access to a consumer's Nara App data in order to assist them to optimize the identification of appropriate natural remedies and monitor a patient's prognosis during treatment. Mindleap.com was acquired in November 2022 when the Company purchased the entire issued share capital for Mindleap Health Inc from Mydecine Innovations Group Inc.
Latest Trades
Date | Volume | Price (GBX) | Value (GBP) |
---|
Latest Announcements
Address
Registered Address
232 – 3800 Wesbrook Mall, Vancouver, British Columbia, V6S 2L9, CanadaPhone
604-218-5788
Contacts
Corporate Adviser
Novum Securities, 2nd Floor Lansdowne House, 57 Berkeley Square, London, W1J 6ER, United KingdomRegistrar
Link Group, 10th Floor, Central Square, 29 Wellington Street, Leeds, LS1 4DL, United Kingdom